Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • NPPA Fixes Retail...

NPPA Fixes Retail Price Of 37 Formulations, Details

Written By : Dr. Divya Colin |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2024-05-24T18:00:00+05:30  |  Updated On 24 May 2024 6:00 PM IST
NPPA Fixes Retail Price Of 37 Formulations, Details
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of the 37 formulations under the Drugs (Prices Control) Order.

This price fixation is followed by decisions made by the National Pharmaceuticals Pricing Authority (NPPA) at its 128th Authority Metting dated on 10th May 2024.

The list includes Akums Drugs and Pharmaceuticals, Abbott Healthcare's Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets, Mascot Health Series, Renon Healthcare's Dapagliflozin, Metformin Hydrochloride and Glimepiride Tablets, Mascot Health Series, Primus Remedies' Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets.

The list further includes Pure and Cure Healthcare, Torrent Pharmaceuticals' Telmisartan, Amlodipine, Hydrochlorothiazide Tablets, Akums Drugs and Pharmaceuticals, Sun Pharmaceuticals Industries' Bilastine and Montelukast oral suspension, Intas Pharmaceuticals' Antacid Antigas gel, Innova Captab, Dr. Reddy's Laboratories' Cefixime and Ofloxacin Oral suspension and etc.

This came exercise of the powers conferred by paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O. 5249(E) dated 11th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (NPPA), has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said table with the strength, unit and name of manufacturer and marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl.

No.

Medicines

Strength

Unit

Manufacturer &

Marketing Company

Retail

Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1

Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets

Each film-coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 1 mg

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s La Renon Healthcare Pvt. Ltd.

14.75

2

Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets

Each film-coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 1 mg

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.

14.53

3

Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets

Each film-coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg

Metformin Hydrochloride IP 1000mg (As Extended release)

Glimepiride IP 1 mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt.

Ltd.

14.75

4

Dapagliflozin, Metformin Hydrochloride

(Extended

Each film-coated bilayered Tablet contains:

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s La Renon

16.00

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Release) and Glimepiride Tablets

Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg

Metformin Hydrochloride IP 1000mg (As Extended release)

Glimepiride IP 2 mg

Healthcare Pvt. Ltd.

5

Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets

Each film-coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg

Metformin Hydrochloride IP 1000mg (As Extended release)

Glimepiride IP 2 mg

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.

16.24

6

Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets

Each film-coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg

Metformin Hydrochloride IP 1000mg (As Extended release)

Glimepiride IP 2 mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt.

Ltd.

16.43

7

Sitagliptin Phosphate, Metformin Hydrochloride, and Glimepiride Tablets

Each film coated Tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg

Metformin Hydrochloride IP 1000mg

Glimepiride IP 1 mg

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.

13.35

8

Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets

Each film coated Tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg

Metformin Hydrochloride IP 1000mg

Glimepiride IP 2 mg

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.

15.03

9

Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets

Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg

Metformin Hydrochloride IP 500mg (As Extended release)

Glimepiride IP 1 mg

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.

13.24

10

Dapagliflozin,

Metformin Hydrochloride

Each film coated bilayered Tablet contains:

Dapagliflozin Propanediol

1 Tablet

M/s Mascot Health Series Pvt. Ltd. /

14.83

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

(Extended Release) and Glimepiride Tablets

USP eq. to Dapagliflozin 10mg

Metformin Hydrochloride IP 500mg (As Extended release)

Glimepiride IP 2 mg

M/s Primus Remedies Pvt. Ltd.

11

Diclofenac Diethylamine, Methyl Salicylate, Virgin Linseed Oil & Menthol Topical spray

Composition:

Diclofenac Diethylamine IP 1.16% w/w eq. to Diclofenac Sodium 1.00% w/w,

Methyl Salicylate IP 10.00% w/w,

Virgin Linseed Oil BP 3.0% w/w,

Menthol IP 5.00% w/w

1 gm

M/s Pontika Aerotech Limited / M/s Unison Pharmaceuticals Pvt. Ltd.

2.73

12

Povidone-Iodine & Ornidazole Ointment

Composition:

Povidone-Iodine IP 5%w/w (Available Iodine 0.5%w/w) Ornidazole IP 1% w/w in an Ointment base

1 gm

M/s Curetech Skincare / M/s J.B. Chemicals & Pharmaceuticals Ltd.

4.11

13

Bisoprolol Fumarate and Telmisartan Tablets

Each film coated Tablet contains:

Bisoprolol Fumarate IP 5 mg Telmisartan IP 40 mg

1 Tablet

M/s Ravenbhel Healthcare Pvt Ltd

/ M/s J.B. Chemicals & Pharmaceuticals

Ltd.

11.21

14

Bisoprolol Fumarate and Telmisartan Tablets

Each film coated Tablet contains:

Bisoprolol Fumarate IP 2.5 mg

Telmisartan IP 40 mg

1 Tablet

M/s Ravenbhel Healthcare Pvt Ltd

/ M/s J.B. Chemicals &

Pharmaceuticals Ltd.

9.65

15

Cefixime and Ofloxacin Oral suspension

Each 5ml reconstituted suspension contains: Cefixime IP as trihydrate eq. to Cefixime Anhydrous 50mg

Ofloxacin IP 50mg

1 ml

M/s Innova Captab Ltd. / M/s Emcure Pharmaceuticals Ltd.

1.90

16

Ibuprofen & Paracetamol Tablets

Each uncoated Tablet contains:

Ibuprofen IP 400mg Paracetamol IP 325mg

1 Tablet

M/s Prochem Pharmaceuticals Pvt. Ltd. / M/s Softdeal Pharmaceuticals

Private Limited

1.59

17

Ranitidine Hydrochloride, Dicyclomine Hydrochloride & Activated Simethicone Tablet

Each film coated Tablet contains:

Ranitidine Hydrochloride IP eq. to Ranitidine 150mg Dicyclomine Hydrochloride IP 10mg

Activated Dimethicone IP

(Simethicone) 20mg

1 Tablet

M/s IndocoRemedies Limited

2.09

18

Telmisartan,

Amlodipine &

Each film coated Tablet

contains:

1 Tablet

M/s Pure and Cure

Healthcare Pvt.

15.96

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Hydrochlorothia zide Tablets

Telmisartan IP 80mg, Amlodipine Besilate IP eq. to Amlodipine 5mg Hydrochlorothiazide IP 12.50mg

Ltd. / M/s Torrent Pharmaceuticals Ltd.

19

Telmisartan, Amlodipine & Hydrochlorothia zide Tablets

Each film coated Tablet contains:

Telmisartan IP 40mg,Amlodipine Besilate IP eq. to Amlodipine 5mgHydrochlorothiazide IP

12.50mg

1 Tablet

M/s Pure and Cure Healthcare Pvt.

Ltd. / M/s Torrent Pharmaceuticals Ltd.

10.45

20

Ceftazidime and Avibactam (As Sodium Salt) powder for concentrate for solution for infusion

Each vial contains: Ceftazidime Pentahydrate (Sterile) eq. to Ceftazidime IP 2.0gm

Avibactam Sodium (Sterile) eq. to Avibactam 0.5gm Sterile Sodium Carbonate IP (anhydrous) 232.9mg

Sodium per vial content 6.44 mmol eq. to 148mg

1 Vial

M/s Aqua Vitoe Laboratories / M/s Emcure Pharmaceuticals Limited

1569.9

4

21

Glimepiride & Metformin Hydrochloride (ER) Tablets

Each uncoated bilayered Tablet contains: Glimepiride IP 4mg Metformin Hydrochloride IP

500mg (In extended-release form)

1 Tablet

M/s Innova Captab Ltd. / M/s Cadila Pharmaceuticals Ltd.

11.28

22

Glimepiride & Metformin Hydrochloride (ER) Tablets

Each uncoated bilayered Tablet contains: Glimepiride IP 3mg Metformin Hydrochloride IP

500mg (In extended-release form)

1 Tablet

M/s Innova Captab Ltd. / M/s Cadila Pharmaceuticals Ltd.

9.84

23

Bilastine and Montelukast oral suspension

Each 5ml suspension contains:

Bilastine 10mg Montelukast Sodium IP eq. to Monelukast 4mg

1 ml

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Sun Pharmaceuticals

Industries Limited

1.72

24

Aceclofenac, Paracetamol & Thiocolchicoside Tablets

Each film coated Tablet contains:

Aceclofenac IP 100mg Paracetamol IP 325mg Thiocolchicoside IP 8mg

1 Tablet

M/s Innova Captab Ltd. / M/s Mankind Pharma Ltd.

25.98

25

Aceclofenac, Paracetamol & Thiocolchicoside Tablets

Each film coated Tablet contains:

Aceclofenac IP 100mg Paracetamol IP 325mg Thiocolchicoside IP 4mg

1 Tablet

M/s Innova Captab Ltd. / M/s Mankind Pharma Ltd.

18.05

26

Hydrocortisone Acetate, Lidocaine, Zinc Oxide &

Each suppository contains: Hydrocortisone Acetate IP 0.25% w/w Lidocaine USP 3.0% w/w

1

Supposi tory

M/s Bliss GVS Pharma Ltd. / M/s Zydus Healthcare

Limited

14.30

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Allantoin Suppositories

Zinc Oxide IP 5.0% w/w Allantoin IP 0.5% w/w

27

Ciprofloxacin & Tinidazole Tablet

Each film coated Tablet contains:

Ciprofloxacin Hydrochloride IP eq. to Ciprofloxacin 500mg

Tinidazole IP 600mg

1 Tablet

M/s Aagya Biotech Pvt. Ltd. / M/s J. B. Chemicals & Pharmaceuticals Ltd.

10.64

28

Fexofenadine Hydrochloride & Montelukast Tablet

Each film coated Tablet contains:

Fexofenadine Hydrochloride IP 120mg

Montelukast Sodium IP eq. to

Montelukast 10mg

1 Tablet

M/s Aagya Biotech Pvt. Ltd. / M/s J. B. Chemicals & Pharmaceuticals Ltd.

15.10

29

Antacid Antigas gel

Each 10ml (two teaspoonful) contains: Dried Aluminium Hydroxide Gel IP (added as paste) 830mg

Magnesium Hydroxide IP (added as paste) 185mg Sodium Carboxymethylcellulose IP 100mg

Simethicone IP 50mg

1 ml

M/s Intas Pharmaceuticals Pvt. Ltd.

0.56

30

Bisoprolol Fumarate and Amlodipine Tablets

Each film coated Tablet contains:

Bisoprolol Fumarate IP 2.5mg

Amlodipine Besylate IP Eq.

to Amlodipine 5mg

1 Tablet

M/s Savi Health Science / M/s Alkem Laboratories Ltd.

6.40

31

Bisoprolol Fumarate and Amlodipine Tablets

Each film coated Tablet contains:

Bisoprolol Fumarate IP 5mg Amlodipine Besylate IP Eq.

to Amlodipine 5mg

1 Tablet

M/s Savi Health Science / M/s Alkem Laboratories Ltd.

8.98

32

Atorvastatin, Clopidogrel & Aspirin Capsule

Each hard gelatine capsule contains:

Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As green coloured pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two reddish brown coloured film coated Tablet, each containg 37.5mg Clopidogrel Tablets IP),

Aspirin IP 75mg (As enteric coated white-coloured

pellets)

1

Capsule

M/s Windlas Biotech Limited / M/s Aristo Pharmaceuticals Pvt. Ltd.

13.84

33

Levocetirizine Dihydrochloride & Montelukast

Each 5ml contains: Levocetirizine Dihydrochloride IP 2.5mg

1 ml

M/s Aagya Biotech

/ M/s J. B. Chemicals &

1.47

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Sodium suspension

Montelukast Sodium IP eq. to Montelukast 4mg

Pharmaceuticals Ltd.

34

Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayered Tablet contains: Linagliptin 5mg

Metformin Hydrochloride IP 500mg (as extended-release

form)

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s Mankind Pharma Limited

12.86

35

Pantoprazole & Domperidone Tablet

Each gastro-resistant Tablet contains: Pantoprazole Sodium IP (as sesquihydrate) eq. to Pantoprazole 40mg

Domperidone IP 10mg

1 Tablet

M/s Innova Captab Ltd. / Dr. Reddy's Laboratories Limited

7.24

36

Chlorphenirami ne Maleate, Dextromethorph an & Phenylephrine Syrup

Each 5ml contains: Chlorpheniramine Maleate IP 2mg

Phenylephrine Hydrochloride IP 5mg Dextromethorphan

Hydrobromide IP 10mg

1 ml

M/s Stedman Pharmaceuticals Pvt. Ltd.

1.02

37

Cefixime and Ofloxacin Oral suspension

Each 5ml reconstituted suspension contains: Cefixime IP as trihydrate eq. to Cefixime Anhydrous 50mg Ofloxacin IP 50mg

1 ml

M/s Innova Captab Ltd. / Dr. Reddy's Laboratories Limited

1.90

The notification further added:

  • The manufacturer of the above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
  • The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.
  • The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from the date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
  • As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
  • The above-mentioned retail price is applicable only to the individual manufacturer/marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
  • In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
  • Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.

To view the notice, click the link below:

https://medicaldialogues.in/pdf_upload/retailprice37-238779.pdf

Also Read: NPPA Fixes Retail Prices of 69 Formulations, Details

nppaprice fixationretail priceTorrent Pharmaintas pharmasun pharmaakums drug
Dr. Divya Colin
Dr. Divya Colin

    Doctor of Pharmacy

    Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Health News Today

    Health Bulletin 09/ May/ 2025

    Health Bulletin 09/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok